What is the share price of Choksi Laboratories Ltd (CHOKSILA) today?
The share price of CHOKSILA as on 12th March 2025 is ₹127. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Choksi Laboratories Ltd (CHOKSILA) share?
The past returns of Choksi Laboratories Ltd (CHOKSILA) share are- Past 1 week: 2.48%
- Past 1 month: -8.46%
- Past 3 months: 99.75%
- Past 6 months: 49.23%
- Past 1 year: 166.87%
- Past 3 years: 400.38%
- Past 5 years: 1227.55%
What are the peers or stocks similar to Choksi Laboratories Ltd (CHOKSILA)?
The peers or stocks similar to Choksi Laboratories Ltd (CHOKSILA) include:What is the market cap of Choksi Laboratories Ltd (CHOKSILA) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Choksi Laboratories Ltd (CHOKSILA) is ₹90.62 Cr as of 12th March 2025.What is the 52 week high and low of Choksi Laboratories Ltd (CHOKSILA) share?
The 52-week high of Choksi Laboratories Ltd (CHOKSILA) is ₹142.40 and the 52-week low is ₹38.32.What is the PE and PB ratio of Choksi Laboratories Ltd (CHOKSILA) stock?
The P/E (price-to-earnings) ratio of Choksi Laboratories Ltd (CHOKSILA) is 80.91. The P/B (price-to-book) ratio is 4.08.Which sector does Choksi Laboratories Ltd (CHOKSILA) belong to?
Choksi Laboratories Ltd (CHOKSILA) belongs to the Health Care sector & Labs & Life Sciences Services sub-sector.How to buy Choksi Laboratories Ltd (CHOKSILA) shares?
You can directly buy Choksi Laboratories Ltd (CHOKSILA) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Choksi Laboratories Ltd
CHOKSILAChoksi Laboratories Ltd
CHOKSILA
Health CareLabs & Life Sciences Services
SmallcapWith a market cap of ₹90 cr, stock is ranked 3,006
High RiskStock is 4.81x as volatile as Nifty
127.002.38% (-3.10)
127.002.38% (-3.10)
Price Chart
High
—
Low
—
Returns
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
Scorecard
Performance
HighThe creamy layer - amongst the top performing stocks
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is not in the overbought zone
Red flags
AvgThe stock has a moderate number of red flags
How to use scorecard? Learn more
Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 70.25 | 4.08 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 47.02 | 5.99 | 0.56% |
Forecast & Ratings
Detailed Forecast —
Forecast data is currently unavailable for this stockPrice
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Choksi Laboratories Ltd provides contract testing and analytical services for pharmaceuticals, food, and environmental monitoring, ensuring compliance and quality assurance.
Peers
Compare with peersDIVISLAB
PE Ratio
92.02
1Y Return
53.86%
Buy Reco %
43.48
SYNGENE
PE Ratio
53.66
1Y Return
0.49%
Buy Reco %
71.43
AARTIPHARM
PE Ratio
30.61
1Y Return
58.84%
Buy Reco %
—
PE Ratio
-21.81
1Y Return
8.51%
Buy Reco %
—
VIMTALABS
PE Ratio
56.42
1Y Return
123.83%
Buy Reco %
100.00
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
Hmm, looks like data is unavailable here. Please come back after some timeRevenue Forecast
Hmm, looks like data is unavailable here. Please come back after some timeEarnings Per Share Forecast
Hmm, looks like data is unavailable here. Please come back after some timeIncome
Balance Sheet
Cash Flow
Annual Normal View
Income Statement
Annual Normal View
| Financial Year | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | TTM | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 25.15 | 29.62 | 30.77 | 34.00 | 28.49 | 26.18 | 30.16 | 37.48 | 36.86 | 41.58 | ||||||||||
Raw Materials | 2.82 | 2.97 | 3.47 | 3.95 | 3.24 | 2.57 | 1.98 | 2.21 | 2.56 | 30.28 | ||||||||||
| Power & Fuel Cost | 0.69 | 0.74 | 0.73 | 0.77 | 0.78 | 0.66 | 0.70 | 0.83 | 0.84 | |||||||||||
| Employee Cost | 7.29 | 8.76 | 10.51 | 11.47 | 11.70 | 10.78 | 11.04 | 12.00 | 13.03 | |||||||||||
| Selling & Administrative Expenses | 6.68 | 5.45 | 6.48 | 7.24 | 5.96 | 4.65 | 4.69 | 6.06 | 6.43 | |||||||||||
| Operating & Other expenses | 2.57 | 6.06 | 2.89 | 3.06 | 6.06 | 2.91 | 2.72 | 3.64 | 3.56 | |||||||||||
EBITDA | 5.10 | 5.64 | 6.69 | 7.51 | 0.75 | 4.61 | 9.03 | 12.74 | 10.44 | 11.30 | ||||||||||
| Depreciation/Amortization | 2.73 | 2.86 | 3.16 | 3.68 | 4.56 | 4.60 | 5.43 | 5.50 | 5.71 | 6.28 | ||||||||||
| PBIT | 2.37 | 2.78 | 3.53 | 3.83 | -3.81 | 0.01 | 3.60 | 7.24 | 4.73 | 5.02 | ||||||||||
| Interest & Other Items | 1.23 | 1.47 | 1.59 | 1.54 | 1.89 | 2.82 | 3.23 | 3.52 | 3.06 | 2.84 | ||||||||||
| PBT | 1.14 | 1.31 | 1.94 | 2.29 | -5.70 | -2.81 | 0.37 | 3.72 | 1.67 | 2.18 | ||||||||||
| Taxes & Other Items | 0.42 | 0.42 | 0.58 | 0.69 | -1.83 | -0.20 | 0.16 | 0.51 | 0.55 | 0.89 | ||||||||||
| Net Income | 0.72 | 0.89 | 1.36 | 1.60 | -3.87 | -2.61 | 0.21 | 3.21 | 1.12 | 1.29 | ||||||||||
| EPS | 1.03 | 1.28 | 1.95 | 2.30 | -5.56 | -3.75 | 0.30 | 4.61 | 1.61 | 1.85 | ||||||||||
| DPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
| Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Company Updates
FY 2015
Annual report
PDFFY 2016
Annual report
PDFFY 2017
Annual report
PDFFY 2018
Annual report
PDFFY 2019
Annual report
PDFFY 2020
Annual report
PDFFY 2021
Annual report
PDFFY 2022
Annual report
PDFFY 2023
Annual report
PDFFY 2024
Annual report
PDFPeers & Comparison
Comparing 3 stocks from
Health CareLabs & Life Sciences Services
Compare valuation on Screener
Health CareLabs & Life Sciences Services
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Choksi Laboratories Ltd | 80.91 | 4.08 | — |
| Divi's Laboratories Ltd | 92.02 | 10.85 | 0.54% |
| Syngene International Ltd | 53.66 | 6.43 | 0.18% |
| Aarti Pharmalabs Ltd | 30.61 | 3.78 | 0.41% |
Price Comparison
Compare CHOKSILA with any stock or ETFCompare CHOKSILA with any stock or ETF
CHOKSILA
Shareholdings
Promoter Holdings Trend
Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
Institutional Holdings Trend
Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
Shareholding Pattern
Shareholding History
Foreign Institutions
smallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
CHOKSILA has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
Dividends
Hmm, looks like data is unavailable here. Please come back after some timeNews & Opinions
Articles & Videos
Earnings
Choksi Laboratories standalone net profit rises 83.33% in the December 2024 quarter
Net profit of Choksi Laboratories rose 83.33% to Rs 0.11 crore in the quarter ended December 2024 as against Rs 0.06 crore during the previous quarter ended December 2023. Sales rose 18.09% to Rs 10.38 crore in the quarter ended December 2024 as against Rs 8.79 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales10.388.79 18 OPM %24.5725.48 - PBDT1.871.57 19 PBT0.190.14 36 NP0.110.06 83 Powered by Capital Market - Live
3 weeks agoCapital Market - Live
Corporate
Choksi Laboratories to announce Quarterly Result
Choksi Laboratories will hold a meeting of the Board of Directors of the Company on 14 February 2025.Powered by Capital Market - Live
1 month agoCapital Market - Live
Earnings
Choksi Laboratories standalone net profit rises 700.00% in the September 2024 quarter
Net profit of Choksi Laboratories rose 700.00% to Rs 0.08 crore in the quarter ended September 2024 as against Rs 0.01 crore during the previous quarter ended September 2023. Sales rose 16.48% to Rs 9.26 crore in the quarter ended September 2024 as against Rs 7.95 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales9.267.95 16 OPM %25.4926.54 - PBDT1.711.42 20 PBT0.100.01 900 NP0.080.01 700 Powered by Capital Market - Live
3 months agoCapital Market - Live
Corporate
Choksi Laboratories to convene board meeting
Choksi Laboratories will hold a meeting of the Board of Directors of the Company on 14 November 2024Powered by Capital Market - Live
4 months agoCapital Market - Live
Corporate
Choksi Laboratories to conduct AGM
Choksi Laboratories announced that the Annual General Meeting (AGM) of the company will be held on 21 September 2024.Powered by Capital Market - Live
6 months agoCapital Market - Live
Corporate
Choksi Laboratories to hold AGM
Choksi Laboratories announced that the Annual General Meeting (AGM) of the company will be held on 21 September 2024.Powered by Capital Market - Live
6 months agoCapital Market - Live
Corporate
Choksi Laboratories to table results
Choksi Laboratories will hold a meeting of the Board of Directors of the Company on 13 August 2024.Powered by Capital Market - Live
7 months agoCapital Market - Live
Lower than Industry Revenue Growth
Over the last 5 years, revenue has grown at a yearly rate of 1.63%, vs industry avg of 4.52%
Decreasing Market Share
Over the last 5 years, market share decreased from 0.28% to 0.21%
Lower than Industry Net Income
Over the last 5 years, net income has grown at a yearly rate of -6.89%, vs industry avg of 5.92%